The effect of diet restriction, separation stress, activity wheel and tyrosine administration on cognitive function and the cholinergic system in mice.
Dramatic depletion of cell surface muscarinic receptor due to limited delivery from intracytoplasmic stores in neurons of acetylcholinesterase-deficient mice.
Attempts to engineer an enzyme mimic of butyrylcholinesterase by substitution of the six divergent aromatic amino acids in the active center of acetylcholinesterase.
Some basic rules governing oligosaccharide-dependent circulatory residence of glycoproteins are revealed by MALDI-TOF mapping of the multiple N-glycans associated with recombinant bovine acetylcholinesterase.
Formation of neuromuscular junctions in co-cultures of human muscle and rat embryonic spinal cord is accompanied by differentiation of neuronal and glial cells.
mRNAs encoding acetylcholinesterase, butyrylcholinesterase and agrin 19 share the same temporal pattern of expression during development of rat spinal cord.
Dopamine release from rat striatal slices in vitro and functional effects in 6-OHDA-treated rats in vivo are mediated by beta2 nicotinic acetylcholine receptors.
Fine-tuning modulation of neuronal muscarinic M1 (facilitatory) and M2 (inhibitory) receptor activation by adenosine at the rat neuromuscular junction.
Probing the binding interface between the nicotinic acetylcholine receptor and a short alpha-neurotoxin through receptor-biotinyltoxin-streptavidin terary complex
PKC and MAP kinase-dependent processing of amyloid precursor protein (APP) by neuroprotective propargylamine cholinesterase inhibitors derived from rasagiline and nonsteroidal anti-inflammatory drugs.
Use of the morphing graphics technique to visualize conformational differences between acetylcholinesterases from different species and inhibitor-induced conformational changes.